 | Up a level |
Boeckhaus, Jan, Hoefele, Julia 
ORCID: 0000-0002-7917-7129, Riedhammer, Korbinian M., Tonshoff, Burkhard, Ehren, Rasmus, Pape, Lars, Latta, Kay, Fehrenbach, Henry, Lange-Sperandio, Baerbel, Kettwig, Matthias, Hoyer, Peter, Staude, Hagen, Konrad, Martin, John, Ulrike, Gellermann, Jutta, Hoppe, Bernd, Galiano, Matthias, Gessner, Michaela, Pohl, Michael, Bergmann, Carsten, Friede, Tim and Gross, Oliver
(2021).
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.
Clin. Genet., 99 (1).
S. 143 - 157.
HOBOKEN:
WILEY.
ISSN 1399-0004
Gellermann, Jutta, Weber, Lutz, Pape, Lars ORCID: 0000-0002-3635-6418, Toenshoff, Burkhard, Hoyer, Peter and Querfeld, Uwe ORCID: 0000-0001-6783-3822
(2013).
Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome.
J. Am. Soc. Nephrol., 24 (10).
S. 1689 - 1698.
WASHINGTON:
AMER SOC NEPHROLOGY.
ISSN 1533-3450
Gross, Oliver, Toenshoff, Burkhard, Weber, Lutz T., Pape, Lars, Latta, Kay, Fehrenbach, Henry, Lange-Sperandio, Baerbel, Zappel, Hildegard, Hoyer, Peter, Staude, Hagen, Koenig, Sabine, John, Ulrike, Gellermann, Jutta, Hoppe, Bernd, Galiano, Matthias, Hoecker, Britta, Ehren, Rasmus, Lerch, Christian, Kashtan, Clifford E., Harden, Markus, Boeckhaus, Jan and Friede, Tim (2020). A multicenter, randomized, placebo -controlled, double-blind phase 3 trial with open -arm comparison indicates safety and ef fi cacy of nephroprotective therapy with ramipril in children with Alport ? s syndrome see commentary. Kidney Int., 97 (6). S. 1275 - 1287. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1755